Jupiter Bioscience Key Ratios
NSE: JUPITER | BSE: 524826
₹3.97
As on 15-Jan-2013IST
Market cap
₹25 Cr
Revenue (TTM)
₹168 Cr
P/E Ratio
--
P/B Ratio
0
Div. Yield
25.2 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -65.65 | -81.93 | -27.86 | 5.86 | 13.62 |
| EBIT | -196.36 | -133.75 | -74.40 | -28.49 | -10.31 |
| Net Profit | -3,828.07 | -234.26 | -107.77 | -144.55 | -165.80 |
| EPS | -3,827.98 | -234.26 | -103.07 | -128.84 | -144.53 |
| Book Value | -- | -- | -31.81 | -5.45 | 12.84 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-11 | Mar-10 |
| EBIT-Margin
| 30.53 | 29.63 | 11.33 | 26.40 | 32.28 |
| Net Margin
| 17.42 | 17.58 | -1.67 | 15.50 | 18.25 |
| Return on equity
| 9.61 | 17.05 | -0.34 | 10.00 | 15.52 |
| Return on Capital
| 8.42 | 11.78 | -- | 8.77 | 11.14 |
| Return on Assets
| 4.42 | 5.72 | -0.45 | 4.59 | 5.51 |
| Debt to Equity (x)
| -- | -- | 0.50 | 0.63 | 1.42 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
--
|
6.81
|
9.07
|
9.39
|
10.91
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-0.34
Lower than Peers by 11.20
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
-0.34
|
7.27
|
11.28
|
10.27
|
13.91
|
|
Peer Median
|
10.86
|
--
|
--
|
--
|
--
|
ROA
-0.45
Lower than Peers by 7.19
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
-0.45
|
3.69
|
4.66
|
4.89
|
6.21
|
|
Peer Median
|
6.74
|
--
|
--
|
--
|
--
|
EBIT Margin
11.33
Lower than Peers by 1.36
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
11.33
|
25.79
|
32.82
|
32.99
|
31.65
|
|
Peer Median
|
12.69
|
--
|
--
|
--
|
--
|
Net Margin
-1.67
Lower than Peers by 10.53
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
-1.67
|
14.84
|
18.01
|
19.41
|
20.63
|
|
Peer Median
|
8.86
|
--
|
--
|
--
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
--
|
32.43
|
37.16
|
38.08
|
34.18
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-27.86
Lower than Peers by 36.00
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
-27.86
|
37.60
|
28.70
|
10.11
|
24.82
|
|
Peer Median
|
8.14
|
--
|
--
|
--
|
--
|
EBIT Growth
-74.40
Lower than Peers by 91.64
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
-74.40
|
8.14
|
28.03
|
14.79
|
27.78
|
|
Peer Median
|
17.24
|
--
|
--
|
--
|
--
|
Net Profit Growth
-107.77
Lower than Peers by 124.63
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
-107.77
|
13.44
|
17.57
|
4.27
|
43.70
|
|
Peer Median
|
16.85
|
--
|
--
|
--
|
--
|
EPS Growth
-103.07
Lower than Peers by 113.67
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
-103.07
|
-70.69
|
17.57
|
17.19
|
-21.85
|
|
Peer Median
|
10.60
|
--
|
--
|
--
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
--
|
134.44
|
11.01
|
3.03
|
128.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.50
Higher than Peers by 0.46
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
0.50
|
0.56
|
1.27
|
0.99
|
0.70
|
|
Peer Median
|
0.04
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.02
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
0.02
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
6.96
Higher than Peers by 5.24
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
6.96
|
6.09
|
11.73
|
6.21
|
4.71
|
|
Peer Median
|
1.72
|
--
|
--
|
--
|
--
|
Quick Ratio
4.00
Higher than Peers by 2.83
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
4.00
|
3.73
|
6.71
|
3.53
|
2.68
|
|
Peer Median
|
1.17
|
--
|
--
|
--
|
--
|
Interest Coverage
0.78
Lower than Peers by 7.09
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
0.78
|
2.57
|
2.61
|
2.84
|
3.86
|
|
Peer Median
|
7.86
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
24.60
Lower than Peers by 1.19
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
24.60
|
25.26
|
23.70
|
26.73
|
25.23
|
|
Peer Median
|
25.79
|
--
|
--
|
--
|
--
|
Asset Turnover
0.27
Lower than Peers by 0.40
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
0.27
|
0.25
|
0.26
|
0.25
|
0.30
|
|
Peer Median
|
0.67
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
--
|
77.53
|
81.17
|
90.60
|
81.81
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
--
|
91.34
|
108.06
|
118.16
|
107.76
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
--
|
20.14
|
28.99
|
36.67
|
22.93
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
--
|
148.73
|
160.24
|
172.10
|
166.64
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
--
|
3.30
|
4.06
|
2.15
|
9.65
|
|
Peer Median
|
39.76
|
--
|
--
|
--
|
--
|
Price / Book Value
0.03
Lower than Peers by 4.18
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
0.03
|
0.17
|
0.44
|
0.22
|
0.97
|
|
Peer Median
|
4.21
|
--
|
--
|
--
|
--
|
Dividend Yield
25.19
Higher than Peers by 25.08
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
25.19
|
5.04
|
2.40
|
5.33
|
1.39
|
|
Peer Median
|
0.10
|
--
|
--
|
--
|
--
|
EV/EBITDA
6.45
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
6.45
|
4.77
|
5.49
|
4.45
|
7.54
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
25
Lower than Peers by 7,359
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-11
|
Mar-10
|
Mar-09
|
Mar-08
|
|---|---|---|---|---|---|
|
Jupiter Bioscience
|
25
|
124
|
135
|
61
|
261
|
|
Peer Median
|
7,384
|
--
|
--
|
--
|
--
|